Selective interaction of homophtalazine derivatives with morphine

European Journal of Pharmacology

Volumn 331, Issue 2-3, 1997, Pages 175-183

  Fekete, Márton I K ^a,c   Horváth, Katalin ^b   Kedves, Rita ^b   Máté, Ildikó ^b   Székely, József I ^b   Szentkuti, Eszter ^b  

^a EGIS PHARMACEUTICALS LTD   (Hungary)

^b Institute for Drug Research Budapest   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Anxiolytics; Benzodiazepine; Dopamine receptor antagonist; Homophtalazine (2,3 benzodiazepine); Opioid; Signal transduction

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; GIRISOPAM; MORPHINE; NERISOPAM;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BINDING SITE; CATALEPSY; CONTROLLED STUDY; DRUG INTERACTION; DRUG POTENCY; ELECTRIC SHOCK; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SUBCUTANEOUS DRUG ADMINISTRATION;

AGGRESSION; ANALGESICS, OPIOID; ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; BENZODIAZEPINES; CATALEPSY; DRINKING; ELECTROSHOCK; MALE; MICE; MICE, INBRED STRAINS; MORPHINE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR; REACTION TIME; SEIZURES;

EID: 0343051883     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01056-X     Document Type: Article

References (43)

1. Ahtee, L., 1976. Effect of cholinergic drugs on methadone-induced catalepsy and stereotypies in rats treated chronically with methadone. Eur. J. Pharmacol. 39, 203-213.
2. Aley, K.O., Kulkarni, S.K., 1991. Baclofen analgesia in mice: A GABA B-mediated response. Methods Find. Exp. Clin. Pharmacol. 13, 681-686.
3. Andrási, F., Horváth, K., Sineger, E., Berzsenyi, P., Borsy, J., Kenessey, Á., Tarr, M., Láng, T., Korösi, J., Hámori, T., 1987. Neuropharmacology of a new psychotropic 2,3-benzodiazepine. Arzneimittelforschung 37, 1119-1124.
4. Bianchi, M., Mantegazza, P., Tammiso, R., Zonta, N., Zambotti, F., 1993. Peripherally administered benzodiazepines increase morphine-induced analgesia in the rat. Arch. Int. Pharmacodyn. Ther. 322, 5-13.
5. Bolton, S., 1990. Pharmaceutical Statistics. Marcel Decker, New York/Basel.
6. Cheng, S.C., Brunner, E.A., 1985. Inducing anesthesia with a GABA analog, THIP. Anesthesiology 63, 147-151.
7. Chopin, P., Stenger, A., Briley, M., 1985. Tofisopam, a 3-4 benzodiazepine, potentiates dopaminergic stimulation. J. Pharm. Pharmacol. 37, 917-919.
8. Cooper, S.J., Jackson, A., Morgan, R., Carter, R., 1985. Evidence for opiate receptor involvement in the consumption of a high palatability diet in nondeprived rats. Neuropeptides 5, 345-348.
9. Costall, B., Naylor, R.J., 1973. Neuroleptic and non-neuroleptic catalepsy. Arzneimittelforschung 23, 674-682.
10. Costall, B., Naylor, R.J., 1974. A role of amygdala in the development of the cataleptic and stereotypic actions of narcotic agonists and antagonists in the rat. Psychopharmacology 35, 203-213.
11. D'Amour, F.E., Smith, D.L., 1941. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72, 74-79.
12. De Montis, M.G., Devoto, P., Meloni, D., Porcella, A., Saba, P., Tagliamonte, A., 1989. Resistance to extrapyramidal effects of opiates in rats chronically treated with SCH 23390. J. Neurosci. Res. 24, 286-292.
13. Engel, J., 1977. Neurochemical aspects of euphoria induced dependence-producing drugs. In: Idestrhom, C.-M. (Ed.), Recent Advances in Study of Alcoholism. Excerpta Medica, Amsterdam, pp. 16-22.
14. Ezrin-Waters, C., Muller, P., Seeman, P., 1976. Catalepsy induced by morphine or haloperidol: Effects of apomorphine and anticholinergic drugs. Can. J. Physiol. Pharmacol. 54, 516-519.
15. Goodman, L.S., Grewal, M.S., Brown, W.C., Swinyard, E.A., 1953. Comparison of maximal seizures evoked by pentylene tetrazol (metrazol) and electroshock in mice and their modification by anticonvulsants. J. Pharmacol. Exp. Ther. 108, 168-176.
16. 5]enkephalin, a delta opioid agonist, given intracerebroventricularly in the mouse produces antinociception through mediation of spinal GABA receptors. Pharmacol. Biochem. Behav. 49, 675-682.
17. Horváth, K., Andrási, F., Berzsenyi, P., Pátfalusi, M., Patthy, M., Szabó, G., Sebestyén, L., Bagdy, E., Botka, P., Hámori, T., Láng, T., 1989. A new psychoactive 5H-2,3-benzodiazepine with unique spectrum of activity. Arzneimittelforschung 39, 894-899.
18. Horváth, K., Andrási, F., Botka, P., Hámori, T., 1992a. Anxiolytic profile of girisopam and GYKI 52 322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone. Acta Physiol. Acad. Sci. Hung. 79, 153-161.
19. Horváth, K., Szentkuti, E., Andrási, F., 1992b. Girisopam and GYKI 52 322 do not potentiate the anticonvulsant and antiaggressive effect of chlordiazepoxide in mice. Pharmacol. Res. 25 (Suppl. 2), 41-42.
20. Horváth, E.J., Hudák, J., Palkovits, M., Lenkei, Z., Fekete, M.I.K., Arányi, P., 1993. A novel specific binding site for homophtalazines in the rat brain. Eur. J. Pharmacol. 236, 151-153.
21. Horváth, E.J., Palkovits, M., Lenkei, Z., Gyüre, K.I., Fekete, M.I.K., Arányi, P., 1994. Autoradiographic localization and quantitative determination of specific binding sites of anxiolytic homophtalazines (formerly called 2,3-benzodiazepines) in striato-pallido-nigral system of rats. Mol. Brain Res. 22, 211-218.
22. Johnston, G.A., 1992. GABA A agonists as targets for drug development. Clin. Exp. Pharmacol. Physiol. 19, 73-78.
23. Kendall, D.A., Browner, M., Enna, S.J., 1982. Comparison of the antinociceptive effect of gamma-aminobutyric acid (GABA) agonists: Evidence for cholinergic involvement. J. Pharmacol. Exp. Ther. 220, 482-487.
24. Kenessey, A., Graf, L., Páldi-Haris, P., Láng, T., 1987. Interaction of 2,3-benzodiazepines with peripheral benzodiazepine receptors. Pharmacol. Res. Commun. 19, 1-14.
25. Koch, J.E., Glass, M.J., Cooper, M.L., Bodnar, R.J., 1995. Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa oipioid antagonists in the hypothalamic paraventricular nucleus of rats. Neurosci. 66, 951-957.
26. Körösi, J., Láng, T., 1971. Heterocyklische Verbindungen I. Synthese des ersten 5H-2,3-Benzodiazepines, des 5-Äthyl-1-(3,4-dimethoxyphenyl)-7,8-dimethoxy-4-methyl-5H-2,3- benzodiazepins. Chem. Ber. 107, 3883-3907.
27. Korösi, J., Lang, T., Székely, J.I., Andrási, F., Zólyomi, G., Borsy, J., Horváth, K., Hámori, T., Czibula, G., Dunai-Kovács, Z., Miglécz, E., 1981. Procedure for synthesis of new 5H-2,3-benzodiazepine derivatives. Patent, HU 179.018 (1980); UK 2,034.706 (1980); USA 4,322.346 (1981).
28. Litchfield, J.T., Wilcoxon, F., 1949. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96, 99-113.
29. Massi, P., Rubino, T., Parenti, M., Giagnoni, G., Gropetti, A., Parolaro, D., 1993. Cholera toxin antagonizes morphine-induced catalepsy through a cyclic AMP-independent mechanism. Eur. J. Pharmacol. 243, 65-71.
30. Paakkari, P., Feuerstein, G., 1988. Antagonism of dermorphin-induced catalepsy with naloxone, TRH-analog CG3703 and the benzodiazepine antagonist, RO 15-1788. Neuropharmacology 27, 1007-1012.
31. Páldi-Haris, P., Gráf, L., Kenessey, A., Lang, T., 1985. Enhancement of low affinity GABA binding by diazepam and a new 2,3-benzodiazepine. Eur. J. Pharmacol. 109, 305-306.
32. Pellow, S., File, S.E., 1986. Is tofisopam an atypical anxiolytic?. Neurosci. Biobehav. Rev. 10, 221-227.
33. Rattan, A.K., Sribanditmonghol, P., 1994. Effect of morphine-induced catalepsy, lethality and analgesia by a benzodiazepine receptor agonist imidazolin in the rat. Pharmacol. Biochem. Behav. 48, 357-361.
34. Rondeau, D.B., Turcotte, M., Young, L., Herbert, D., 1982. Similarities of the cataleptic state induced by beta-endorphin and morphine. Pharmacol. Biochem. Behav. 17, 703-707.
35. Rocha, L., Tatsukawa, K., Chugani, J. Jr., 1993. Benzodiazepine receptor binding following chronic treatment with naloxone, morphine and met-enkephalin in normal rats. Brain Res. 612, 247-252.
36. Saano, V., Urtti, A., 1982. Tofisopam modulates the affinity of benzodiazepine receptors in rat brain. Pharmacol. Biochem. Behav. 17, 367-369.
37. Salamon, C., Horváth, E.J., Fekete, M.I.K., Arányi, P., 1992. A novel specific binding site for anxiolytic homophtalazines in the rat brain. FEBS Lett. 308, 215-217.
38. Sawynok, J., 1987. GABAergic mechanisms of analgesia: An update. Pharmacol. Biochem. Behav. 26, 463-474.
39. Sivam, S.P., Ho, K.I., 1983. GABAergic drugs, morphine and morphine tolerance: A study in relation to nociception and gastrointestinal transit in mice. Neuropharmacology 22, 767-774.
40. Sivam, S.P., Ho, K.I., 1985. GABA in morphine analgesia and tolerance. Life Sci. 37, 199-208.
41. Swinyard, E.A., Brown, W.C., Goodman, L.S., 1952. Comparative assays of antiepileptic drugs in mice and rats. J. Pharmacol. Exp. Ther. 106, 319-330.
42. Tedeschi, R.E., Tedeschi, D.H., Mucha, A., Cook, L., Mattis, P.A., Fellows, E.J., 1959. Effects of various centrally acting drugs on fighting behaviour of mice. J. Pharmacol. Exp. Ther. 125, 28-34.
43. Zarrindast, M.R., Zarghi, A., 1992. Morphine stimulates locomotor activity by an indirect dopaminergic mechanism: Possible D-1 and D-2 receptor involvement. Gen. Pharmacol. 23, 1134-1221.